Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -0.31 is 28% above its 5-year average of -0.43, near the low end of its 5-year range (-0.84–3.62).
As of the fiscal period ended Tuesday, June 30, 2026. 19.49% above its 12-month average of -0.38.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -0.31.
DEBT TO EQUITY RATIO
-0.31
DEBT TO EQUITY RATIO AVG TTM
-0.38
DEBT TO EQUITY RATIO AVG 3Y
-0.45
DEBT TO EQUITY RATIO AVG 5Y
-0.43
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+19.49%
CURRENT VS 3Y AVG
+31.13%
CURRENT VS 5Y AVG
+27.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-381.75%
vs the sector median at left
Scilex Holding Company
Market Cap
$33.63M
Debt to Equity Ratio
-0.31
TTM Avg
-0.38
3Y Avg
-0.45
5Y Avg
-0.43
Market Cap
$33.61M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$33.29M
Debt to Equity Ratio
0.11
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.10
Market Cap
$32.93M
Debt to Equity Ratio
0.41
TTM Avg
0.57
3Y Avg
0.43
5Y Avg
0.47
Market Cap
$34.97M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$35.52M
Debt to Equity Ratio
1.93
TTM Avg
0.81
3Y Avg
0.39
5Y Avg
0.65
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $33.63M | -0.31 | -0.38 | -0.45 | -0.43 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | 0.00 | 0.00 | 0.00 | 0.00 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | 0.11 | 0.10 | 0.11 | 0.10 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | 0.41 | 0.57 | 0.43 | 0.47 |
| Elutia Inc (ELUT)vs › | $34.35M | 0.69 | 0.40 | 0.40 | 1.20 |
| Nephros, Inc. (NEPH)vs › | $32.79M | 0.07 | 0.13 | 0.17 | 0.16 |
| HeartBeam, Inc. (BEAT)vs › | $32.42M | 0.00 | 0.00 | 0.00 | 0.00 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00 | 0.00 | 0.00 | 0.00 |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | 1.93 | 0.81 | 0.39 | 0.65 |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 0.50 | 0.49 | 0.49 | 0.65 |
Debt/Equity
-0.31
Current Ratio
0.07
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -0.31 |
| 2026-03-31 | -0.43 |
| 2025-12-31 | -0.64 |
| 2025-09-30 | -0.38 |
| 2025-06-30 | -0.17 |
| 2025-03-31 | -0.20 |
| 2024-12-31 | -0.20 |
| 2024-09-30 | -0.48 |
| 2024-06-30 | -0.50 |
| 2024-03-31 | -0.59 |
| 2023-12-31 | -0.74 |
| 2023-09-30 | -0.77 |
| 2023-06-30 | 3.62 |
| 2023-03-31 | 0.98 |
| 2022-12-31 | 0.04 |
| 2022-09-30 | -0.49 |
| 2022-06-30 | -0.75 |
| 2022-03-31 | -0.84 |
| 2021-12-31 | -0.69 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | -0.98 |
| 2020-09-30 | -0.96 |
| 2020-06-30 | -0.96 |
| 2020-03-31 | -0.96 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
